Holen Sie sich die Stockscreener-App
22.30
3.55%
-0.82
Handel nachbörslich:
22.30
Schlusskurs vom Vortag:
$23.12
Offen:
$23.23
24-Stunden-Volumen:
1.07M
Relative Volume:
0.92
Marktkapitalisierung:
$2.99B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-151.09M
KGV:
-14.29
EPS:
-1.56
Netto-Cashflow:
$-160.51M
1W Leistung:
-1.41%
1M Leistung:
+23.68%
6M Leistung:
+108.22%
1J Leistung:
+38.68%
1-Tages-Spanne:
$22.30
$23.23
1-Wochen-Bereich:
$22.26
$23.67
52-Wochen-Spanne:
$9.60
$24.57
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile
Firmenname
Centessa Pharmaceuticals Plc Adr
Sektor
Branche
Telefon
44 7391 789784
Adresse
3RD FLOOR, ALTRINCHAM, CHESHIRE
Vergleichen Sie CNTA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNTA
Centessa Pharmaceuticals Plc Adr
|
22.30 | 3.10B | 0 | -151.09M | -160.51M | -1.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.15 | 105.19B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
450.68 | 60.24B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.86 | 61.82B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
798.94 | 49.09B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
351.09 | 37.52B | 4.56B | -176.77M | 225.30M | -1.7177 |
Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-03 | Eingeleitet | Wells Fargo | Overweight |
| 2025-08-29 | Fortgesetzt | Oppenheimer | Outperform |
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-05-28 | Eingeleitet | Needham | Buy |
| 2025-05-08 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-31 | Eingeleitet | Piper Sandler | Overweight |
| 2025-01-07 | Eingeleitet | TD Cowen | Buy |
| 2024-09-20 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
| 2024-07-18 | Eingeleitet | Oppenheimer | Outperform |
| 2023-11-15 | Hochstufung | Jefferies | Hold → Buy |
| 2023-10-26 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2023-06-21 | Eingeleitet | Evercore ISI | Outperform |
| 2023-06-12 | Eingeleitet | Guggenheim | Buy |
| 2023-03-17 | Eingeleitet | SVB Securities | Outperform |
| 2022-08-12 | Herabstufung | Morgan Stanley | Overweight → Underweight |
| 2022-06-17 | Eingeleitet | BMO Capital Markets | Outperform |
| 2022-06-03 | Herabstufung | Jefferies | Buy → Hold |
| 2022-02-11 | Eingeleitet | Goldman | Neutral |
Alle ansehen
Centessa Pharmaceuticals Plc Adr Aktie (CNTA) Neueste Nachrichten
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Stake Reduced by GAMMA Investing LLC - Defense World
Centessa Pharmaceuticals (CNTA) Receives a Buy from Piper Sandler - The Globe and Mail
Tanager Wealth Management LLP Decreases Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Platinum Investment Management Ltd. Has $3.82 Million Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Hits New 12-Month HighWhat's Next? - MarketBeat
Centessa Pharmaceuticals stock hits 52-week high at 24.17 USD By Investing.com - Investing.com Nigeria
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Rating of “Buy” by Brokerages - Defense World
Centessa Pharmaceuticals stock hits 52-week high at 24.17 USD - Investing.com India
Centessa Pharmaceuticals PLC Sponsored ADR (NASDAQ:CNTA) Given Consensus Rating of "Buy" by Brokerages - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Sets New 1-Year HighTime to Buy? - MarketBeat
Centessa Pharmaceuticals’ Bush sells $840,000 in shares - Investing.com India
Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) CTO Sells $840,000.00 in Stock - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Sets New 12-Month HighHere's What Happened - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Reaches New 1-Year High – Should You Buy? - Defense World
Insider Selling: Centessa Pharmaceuticals (NASDAQ:CNTA) Insider Sells 8,172 Shares of Stock - MarketBeat
Centessa Pharmaceuticals stock hits 52-week high at 23.51 USD By Investing.com - Investing.com Australia
Centessa Pharmaceuticals (NASDAQ:CNTA) General Counsel Iqbal J. Hussain Sells 6,000 Shares - MarketBeat
Centessa Pharmaceuticals stock hits 52-week high at 23.51 USD - Investing.com
Woodline Partners LP Lowers Stock Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Ellsworth Advisors LLC Buys Shares of 48,872 Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Fred Alger Management LLC Has $2.11 Million Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharma general counsel sells $131k in shares By Investing.com - Investing.com South Africa
Centessa Pharma general counsel sells $131k in shares - Investing.com India
Centessa Pharmaceuticals (NASDAQ:CNTA) Hits New 1-Year HighShould You Buy? - MarketBeat
Centessa Pharmaceuticals (NASDAQ:CNTA) Shares Gap UpHere's Why - MarketBeat
Centessa Pharma chief technology officer sells $1m in shares - Investing.com India
What is Lifesci Capital's Forecast for CNTA Q3 Earnings? - MarketBeat
Centessa Pharmaceuticals stock hits 52-week high at 19.1 USD By Investing.com - Investing.com Australia
Centessa Pharmaceuticals PLC Sponsored ADR $CNTA Shares Acquired by Cutter Capital Management LP - MarketBeat
Cormorant Asset Management LP Lowers Holdings in Centessa Pharmaceuticals PLC Sponsored ADR $CNTA - MarketBeat
Centessa Pharmaceuticals stock hits 52-week high at 19.1 USD - Investing.com
Jefferies Remains a Buy on Centessa Pharmaceuticals (CNTA) - The Globe and Mail
Alibaba, Palantir Lead Market Cap Stock Movers on Monday By Investing.com - Investing.com South Africa
Alibaba, Palantir Lead Market Cap Stock Movers on Monday - Investing.com
Finanzdaten der Centessa Pharmaceuticals Plc Adr-Aktie (CNTA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.05%
4.71%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):